We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.89B
AUM Growth
+$232M
Cap. Flow
+$22.2M
Cap. Flow %
0.45%
Top 10 Hldgs %
7.1%
Holding
1,417
New
62
Increased
609
Reduced
305
Closed
113

Top Buys

Rank Stock Value
1
MBC icon
MasterBrand
MBC
+$17.7M
2
MLKN icon
MillerKnoll
MLKN
+$17.4M
3
VYX icon
NCR Voyix
VYX
+$14.9M
4
RTX icon
RTX Corp
RTX
+$8.92M
5
COST icon
Costco
COST
+$7.64M

Top Sells

Rank Stock Value
1
ARCB icon
ArcBest
ARCB
+$19.4M
2
NVDA icon
NVIDIA
NVDA
+$19.4M
3
CHS
Chicos FAS, Inc.
CHS
+$11.7M
4
AROC icon
Archrock
AROC
+$11.3M
5
CTRA
Coterra Energy
CTRA
+$7.93M

Sector Composition

Rank Sector Weight
1 Financials 25.84%
2 Consumer Discretionary 12.72%
3 Industrials 12.57%
4 Technology 11.39%
5 Energy 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UUU icon
1151
Universal Safety Products Inc
UUU
$10.6M
$152K ﹤0.01%
95,980
CLYM
1152
Climb Bio
CLYM
$804M
$151K ﹤0.01%
55,223
AWRE icon
1153
Aware
AWRE
$27.7M
$151K ﹤0.01%
80,679
EGAN icon
1154
eGain
EGAN
$201M
$150K ﹤0.01%
23,200
SGMO
1155
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$149K ﹤0.01%
222,300
-72,700
-25% -$52.7K
SRFM icon
1156
Surf Air Mobility
SRFM
$95.8M
$148K ﹤0.01%
+25,000
New +$195K
PRPH
1157
DELISTED
ProPhase Labs
PRPH
$147K ﹤0.01%
2,278
+17
+0.8% +$861
QNCX icon
1158
Quince Therapeutics
QNCX
$29.5M
$147K ﹤0.01%
692
PETS icon
1159
PetMed Express
PETS
$42.3M
$146K ﹤0.01%
+30,500
New +$177K
CNTX icon
1160
Context Therapeutics
CNTX
$44.5M
$146K ﹤0.01%
105,809
GROV icon
1161
Grove Collaborative
GROV
$46.1M
$145K ﹤0.01%
87,025
KPLT icon
1162
Katapult Holdings
KPLT
$33.2M
$145K ﹤0.01%
12,416
BRBS icon
1163
Blue Ridge Bankshares
BRBS
$332M
$144K ﹤0.01%
53,612
-119,305
-69% -$325K
HCWB icon
1164
HCW Biologics
HCWB
$5.45M
$141K ﹤0.01%
353
LTRX icon
1165
Lantronix
LTRX
$266M
$140K ﹤0.01%
39,400
MGYR icon
1166
Magyar Bancorp
MGYR
$123M
$140K ﹤0.01%
12,579
ZDGE icon
1167
Zedge
ZDGE
$38.9M
$140K ﹤0.01%
50,480
CGTX icon
1168
Cognition Therapeutics
CGTX
$96.7M
$140K ﹤0.01%
76,700
-14,500
-16% -$29.9K
CULP icon
1169
Culp Inc
CULP
$44.1M
$139K ﹤0.01%
28,900
ICD
1170
DELISTED
Independence Contract Drilling, Inc.
ICD
$138K ﹤0.01%
74,380
RMCF icon
1171
Rocky Mountain Chocolate Factory
RMCF
$7.84M
$138K ﹤0.01%
38,100
INZY
1172
DELISTED
Inozyme Pharma
INZY
$136K ﹤0.01%
17,800
-34,000
-66% -$187K
IMUX icon
1173
Immunic
IMUX
$195M
$136K ﹤0.01%
10,280
-1,000
-9% -$13K
BMTX
1174
DELISTED
BM Technologies, Inc.
BMTX
$132K ﹤0.01%
80,169
-16,039
-17% -$30.9K
VNRX icon
1175
VolitionRx Ltd
VNRX
$9.34M
$132K ﹤0.01%
8,709
-96
-1% -$1.88K

Similar funds

Bridgeway Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Bridgeway Capital Management held 1,417 positions worth $4.89B, up 5% from $4.66B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.

Bridgeway Capital Management's Q1 2024 filing shows 62 new, 609 increased, 305 reduced and 113 closed positions. Its largest new stake was MasterBrand: 1,114,946 shares worth $20.9M. The largest sale was ArcBest, an estimated $19.4M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 27% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q1 2024 buy was MasterBrand: 1,114,946 shares worth $20.9M.
  • Bridgeway Capital Management added most to RTX Corp in Q1 2024, an estimated $8.92M increase.
  • Bridgeway Capital Management's biggest Q1 2024 reduction was ArcBest, cutting an estimated $19.4M.
  • Bridgeway Capital Management fully exited Chicos FAS, Inc. in Q1 2024, selling an estimated $11.7M.
  • Bridgeway Capital Management's ten largest holdings make up 7.1% of its $4.89B portfolio in Q1 2024.
  • Bridgeway Capital Management opened 62 new positions and closed 113 in Q1 2024.
  • Bridgeway Capital Management's portfolio value rose 5% quarter-over-quarter to $4.89B.

Based on Bridgeway Capital Management's 13F filing for Q1 2024, filed 15 May 2024.